This barrier is unrelated to the end of the transition period, following the United Kingdom's departure from the EU.


Lack of comprehensive cost-benefit evaluation for medical products in Panama disadvantages UK exporters

in Panama

Trade barrier summary

Government purchases of medicines and medical products does not follow a comprehensive cost-benefit evaluation of the product. This makes it difficult for UK companies looking to introduce new and innovative technologies and treatments in the market.

Sectors affected

  • Healthcare services
  • Pharmaceuticals and biotechnology



Date reported

23 April 2021

Last updated

26 November 2021

Public ID


Back to search results

If a trade barrier is affecting your exports or investment from the UK, please let us know on report a trade barrier .

If you export goods you can check duties and customs procedures for your chosen market.